Gender Comparison of Veterans Crisis Line Risk Ratings and Consequent Suicidal Self‐Directed Violence Outcomes During the COVID Era
Suicide and Life-Threatening Behavior · 2025
DOI: 10.1111/sltb.13162 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Suicide and Life-Threatening Behavior, 2025. Verfasst von Sumedha Chhatre und 4 weiteren Autor:innen. Beteiligte Einrichtung: U.S. Department of Veterans Affairs, Center for Health Equity Research and Promotion, Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: COVID-19, Veterans, Suicide, Attempted. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Veterans Affairs, Health Services Research and Development, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Introduction
Improving gender‐sensitive suicide prevention programming for women veterans is crucial. Veterans Crisis Line (VCL) is a preventive strategy used by the US Department of Veterans Affairs. Public health measures implemented during COVID‐19 pandemic may have affected the nature of VCL calls.
Objectives
To assess the gender differences in the VCL contacts made in year 2020 and subsequent suicidal self‐directed violence (SSDV) outcomes in the 12 months follow‐up.
Methods
Cohort study. Outcomes Composite measure of SSDV (dichotomized as nonfatal suicide event and/or suicide) in the 12 months following VCL call.
Results
Compared to veterans with low‐risk assessment, those with high/moderate risk had significantly higher odds of SSDV in the follow‐up year (OR = 4.12, 95% CI: 3.82, 4.45). We assessed the association of gender, combination of VCL risk, and suicide attempt (SA) history, on SSDV. The VCL risk and SA history combinations were independently associated with SSDV. However, there was no differential association on SSDV for different gender/VCL risk and SA history combinations ( p = 0.6247). Conclusions and Relevance Our 2020 VCL data outcomes are largely consistent with those from our prior work examining 2018 VCL contacts. Overall, VCL risk assessment was relatively stable across the gender binary during COVID pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- U.S. Department of Veterans Affairs, Center for Health Equity Research and Promotion, Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- VA Rocky Mountain Mental Illness Research, Education and Clinical Center for Veteran Suicide Prevention, Aurora, Colorado, USA.
- Department of Physical Medicine and Rehabilitation, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- U.S. Department of Veterans Affairs, Veterans Crisis Line, Office of Suicide Prevention, VA Central Office, Washington, DC, USA.
- Temple University School of Social Work, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Sumedha Chhatre, Claire A Hoffmire, Melissa Dichter
Förderung
- Veterans Affairs, Health Services Research and Development
- U.S. Department of Veterans Affairs
Zitieren
APA
Chhatre, S., Hoffmire, C. A., Podlogar, M. C., Agha, A. Z., & Dichter, M. (2025). Gender Comparison of Veterans Crisis Line Risk Ratings and Consequent Suicidal Self‐Directed Violence Outcomes During the COVID Era. Suicide and Life-Threatening Behavior. https://doi.org/10.1111/sltb.13162
Vancouver
Chhatre S, Hoffmire CA, Podlogar MC, Agha AZ, Dichter M. Gender Comparison of Veterans Crisis Line Risk Ratings and Consequent Suicidal Self‐Directed Violence Outcomes During the COVID Era. Suicide and Life-Threatening Behavior. 2025. doi:10.1111/sltb.13162
BibTeX
@article{Chhatre2025,
author = {Chhatre, Sumedha and Hoffmire, Claire A and Podlogar, Matthew C and Agha, Aneeza Z and Dichter, Melissa},
title = {Gender Comparison of Veterans Crisis Line Risk Ratings and Consequent Suicidal Self‐Directed Violence Outcomes During the COVID Era},
journal = {Suicide and Life-Threatening Behavior},
year = {2025},
doi = {10.1111/sltb.13162}
}
EUVIMED